![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Siemens Healthineers Receives CE Mark for Atellica Advanced Diagnostics System
Siemens Healthineers Receives CE Mark for Atellica Advanced Diagnostics System
![ApprovedGreen.gif](https://www.fdanews.com/ext/resources/test/Drug-Images3/ApprovedGreen.gif?t=1576044289&width=430)
September 27, 2017
Siemens Healthineers won CE Mark for its Atellica Solution advanced diagnostic system. The system consists of scalable immunoassay and chemistry analyzers, the company said, and can operate as an independent system or connect to Aptio Automation.
The system features an immunoassay analyzer that can run up to 440 tests per hour, making use of a dual incubation ring design, temperature and humidity controls, magnets for relevant particle separation and robust washing protocols.
The device also includes a bi-directional, magnetic transport technology called Atellica Magline Transport, which gives laboratories control over every sample.
The Atellica Solution can process more than 30 different sample container types. It includes 170 assays and a 10-minute turnaround for certain cardiac, reproductive and thyroid tests. It’s now available in Europe, the U.S., South America and Asia.
Upcoming Events
-
21Oct